JORDAN DICKEN: Open Payments
NPI 1073019659 · NEW CASTLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,067 in 65 payments from 11 companies in 2025. Trend: 2023 $228 · 2024 $969 · 2025 $1,067
Food & beverage: $1,067
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $291 |
| PFIZER INC. | 21 | $286 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $139 |
| ABIOMED | 2 | $65 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $59 |
| Boston Scientific Corporation | 2 | $52 |
| Amgen Inc. | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Esperion Therapeutics, Inc. | 2 | $28 |
Products named: ELIQUIS, CAMZYOS, JARDIANCE, VYNDAQEL, LifeVest, WATCHMAN FLX, REPATHA, BRILINTA.
Industry payments across IN — which companies pay providers there.
